What is NAFLD/NASH?
(Nonalcoholic Fatty
Liver Disease/Nonalcoholic Steatohepatitis)
What is fatty liver?
In fatty liver, fat accumulates in the liver cells.
Simple fatty liver usually does not damage the liver, but is a condition
that can be identified by taking a sample of liver tissue (liver biopsy)
and examining it under a microscope.
What causes fatty liver?
Fat may accumulate in the liver with extreme weight
gain or diabetes mellitus. Fatty liver can also occur with poor diet and
certain illnesses, such as tuberculosis, intestinal bypass surgery for
obesity, and certain drugs such as corticosteroids, or in the setting of
heavy alcohol use. A patient has fatty liver when the fat makes up at
least 10% of the liver. Eating fatty food by itself does not produce a
fatty liver.
Simple fatty liver is not associated with any other liver abnormalities
such as scarring or inflammation. It is a common finding in patients who
are very overweight or have diabetes mellitus.
Alcoholism could also result in inflammation of the liver (alcoholic
hepatitis) and/or scarring (alcoholic cirrhosis) and needs to be
differentiated from NASH by patient history.
Possible explanations for fatty liver include the transfer of fat from
other parts of the body, or an increase in the extraction of fat
presented to the liver from the intestine. Another explanation is that
the fat accumulates because the liver is unable to change it into a form
that can be eliminated.
How is fatty liver diagnosed?
Fatty liver is usually suspected in a patient with the
diseases or conditions described above. The patient may have an enlarged
liver or minor elevation of liver enzyme tests. Several studies show
that fatty liver is one of the most common causes of isolated minor
elevation of liver enzymes found in routine blood screening.
In diagnosing fatty liver, the physician will first eliminate the other
possible causes of chronic liver disease, especially alcohol abuse.
Images of the liver obtained by an ultrasound test, a computed
tomography (CT) scan, or a magnetic resonance imaging (MRI) scan, can
suggest the presence of a fatty liver. In the ultrasound test, a fatty
liver will produce a bright image in a ripple pattern. A CT scan will
show a liver that is less dense than normal.
The diagnosis must be confirmed by a liver biopsy, a procedure where the
physician inserts a needle into the liver and extracts a sample of
tissue, which is examined under a microscope.
How is fatty liver treated?
The treatment of fatty liver is related to the cause.
It is important to remember that simple fatty liver does not require
treatment, since it does not result in damage to liver cells. Obese
patients with fatty liver will have reduction or loss of excess fat in
liver cells, as well as in other cells in the body, if substantial
weight loss can be achieved. Good control of diabetes mellitus with
diet, drugs, or insulin also decreases the fat content in the liver.
What is nonalcoholic steatohepatitis?
Nonalcoholic steatohepatitis (NASH) is described as
inflammation of the liver associated with the accumulation of fat in the
liver. It differs from the simple accumulation of fat in the liver
(fatty liver, or hepatic steatosis) in that the inflammation causes
damage to the liver cells while simple fatty liver probably does not.
NASH is not connected with other causes of chronic liver disease,
including hepatitis B and C viruses, autoimmune disorders, alcohol, drug
toxicity, and the accumulation of copper (Wilson’s Disease) or iron (hemochromatosis).
What causes NASH?
There is no known specific cause of NASH. In the past,
the typical NASH patient was described as a middle-aged, obese woman
with excess sugar in the blood, which may have been caused by diabetes
mellitus. The patient may have had excess fat in the blood. However, it
has recently been reported that patients with NASH do not always fit
this description. One study included men, as well as women, who were not
overweight, did not suffer from diabetes mellitus, and did not have
excess lipids (fat) in their blood. Another group diagnosed with NASH
was composed of children between nine and 16 years old. Most of the
children were overweight, but only a few had diabetes mellitus.
What is the risk of NASH?
In NASH, which resembles alcoholic steatohepatitis,
the inflammation of the liver is associated with an increase of fat
deposits and typically occurs in middle-aged, overweight, and often
diabetic patients who do not drink alcohol. It has also been connected
with rapid weight loss, or in women taking hormones (estrogen). The
fatty tissue in the liver may break up liver cells (steatonecrosis) and
the patient may develop cirrhosis (scarring of the liver). Recent
studies indicate that NASH can result in the development of fibrous
tissue in the liver (fibrosis) in up to 40% of
patients or cirrhosis in 5-10% of patients. It is not certain why some
NASH patients will progress to this serious form of chronic liver
disease while others do not. Studies report that the progression to
fibrosis or cirrhosis for NASH patients is variable but can occasionally
occur in less that 20 years.
Some studies have shown that 20% to 40% of people who are grossly
overweight will develop NASH. If a patient is grossly overweight,
however, it does not mean that he/she will develop NASH. Many patients
with NASH will show an increase of certain iron proteins (ferritin) in
their blood, but whether this relates to any injury to the liver is
unknown.
How is NASH diagnosed?
Many NASH patients are unaware of their conditions
because they do not exhibit any symptoms. In most cases, NASH causes a
slight increase during liver enzyme tests, as do other forms of liver
disease.
AS with fatty liver, the physician will first eliminate the other
possible causes of chronic liver disease. Images of the liver are
obtained by an ultrasound test, a CT scan, or an MRI scan. The diagnosis
must be confirmed by liver biopsy.
How is NASH treated?
Presently, there is no specific treatment for NASH
that is universally agreed upon. However, patients who are obese,
diabetic, and have high lipids (fats) in their blood are advised to lose
weight and control their diabetes and elevated lipids. Usually, a low
fat, low calorie diet is recommended along with insulin or medications
to lower blood sugar for diabetes. For many patients with NASH who are
not overweight and not diabetic, a low fat diet is recommended. Patients
with NASH should avoid alcohol or other substances that could be
harmful to the liver. More research is needed to understand what causes
NASH so that more effective therapies can be developed.
Information from the
American Liver Foundation
Return
to My RA Experience
|
Copyright ©
2007-2010 Donmeanie
Comments and/or questions about the website, contact the
Webmaster |
|